Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
3.8K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

3.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
The Nucleolus02:55

The Nucleolus

10.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.6K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

4.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
4.2K
Types of RNA01:20

Types of RNA

10.2K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Mechanism of Silymarin Extract for Deep Second-Degree Burns in Rats.

Chinese journal of integrative medicine·2026
Same author

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Interpretable Multimodal Graph Learning Platform for Rational Design of AIEgens: From Molecular Structure and Microenvironments to Photophysical Properties.

ACS sensors·2026
Same author

Synthesis and biological evaluation of phenanthridine derivatives as dual-target inhibitors of DNA topoisomerase IB (TOP1) and tyrosyl-DNA phosphodiesterase 1 (TDP1), and potential antitumor agents.

European journal of medicinal chemistry·2026
Same author

An optimal imaging modality based on different predictive risk factors for evaluating local staging of rectal cancer preoperatively: a comparative study of MRI and endorectal ultrasound.

Quantitative imaging in medicine and surgery·2025
Same author

Tracing chemical weathering dynamics during seasonal variability and storm in the Gaoping (Kaoping) and Choushui Rivers, Western Taiwan: Insight from Li isotope.

The Science of the total environment·2025

Related Experiment Video

Updated: Mar 6, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

lncRNAs: key player in Aβ deposition.

Ruo-Mei Wang1,2, Zi-Qiang Wang1,2

  • 1Department of Nuclear Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.

RNA Biology
|March 5, 2026
PubMed
Summary

Long non-coding RNAs (LncRNAs) are crucial in Alzheimer's disease (AD) progression by influencing amyloid-beta (Aβ) plaque deposition. This review explores LncRNA pathways and their therapeutic potential for AD treatment.

Keywords:
Alzheimer’s diseaseLong non-coding RNAsamyloid-betacompetitive endogenous RNAsnatural antisense transcripts

More Related Videos

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
10:34

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture

Published on: July 22, 2016

24.5K
RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

26.4K

Related Experiment Videos

Last Updated: Mar 6, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K
Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
10:34

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture

Published on: July 22, 2016

24.5K
RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

26.4K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder marked by amyloid-beta (Aβ) plaque accumulation.
  • Aβ is generated by secretase enzymes cleaving amyloid precursor protein, leading to neuronal damage via oxidative stress and inflammation.
  • Long non-coding RNAs (LncRNAs) are non-protein-coding transcripts involved in gene regulation and neuronal function.

Purpose of the Study:

  • To review the mechanisms by which LncRNAs influence Aβ deposition in Alzheimer's disease.
  • To classify LncRNAs based on their modes of action in AD pathogenesis.
  • To discuss current research challenges and future therapeutic prospects of LncRNAs in AD treatment.

Main Methods:

  • Literature review of studies on LncRNAs and Alzheimer's disease.
  • Classification of LncRNAs based on their functional pathways affecting Aβ deposition.
  • Synthesis of current research findings and identification of knowledge gaps.

Main Results:

  • LncRNAs play a significant role in regulating Aβ production and clearance.
  • Specific LncRNAs have been identified that modulate pathways involved in Aβ deposition.
  • LncRNAs influence AD progression through various mechanisms including gene expression and chromatin remodeling.

Conclusions:

  • LncRNAs represent a promising area for understanding and treating Alzheimer's disease.
  • Targeting LncRNAs offers potential therapeutic strategies to reduce Aβ burden.
  • Further research is needed to fully elucidate LncRNA functions and develop effective AD therapies.